Differential binding of hyaluronic acid in two CD44+ sublines. Relationship with tumor infiltration;Union diferencial de acido hialuronico en dos sublineas celulares CD44+ posible implicancia en la infiltracion tumoral

Medicina

Volumn 60, Issue 6, 2000, Pages 931-939

  Ernst, Glenda M ^b   Lopes, Eloisi Caldas ^b   Cabrera, Paula V ^b   Alvarez, Elida ^b   Hajos, Silvia E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

CD44; HA binding; Tumor cell lines

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; IMMUNOLOGICAL ADJUVANT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER INVASION; CELL CULTURE; CELL DIVISION; CONFIDENCE INTERVAL; FLOW CYTOMETRY; METABOLISM; MOUSE; PATHOLOGY; PROTEIN BINDING; T CELL LEUKEMIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD44; CELL DIVISION; CONFIDENCE INTERVALS; FLOW CYTOMETRY; HYALURONIC ACID; LEUKEMIA, T-CELL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PROTEIN BINDING; TUMOR CELLS, CULTURED;

EID: 0041347809     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Picker JL, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992; 10: 561-7.
2. Stauder R, Gunthert U. CD44 isoforms. Impact on lymphocyte activation and differentiation. The Immunologist 1995; 3: 78-83.
3. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998; 93: 139-48.
4. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 1996; 132: 1199-228.
5. Ponta H, Sleeman J, Dall P, MOII J, Sherman L, Herrlich P. CD44 isoform in metastatic cancer. Invasion metastasis 1994; 14: 82-6.
6. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with malignant process. Adv Cancer Res 1997; 71: 241-319.
7. Lesley J, English N, Perschl A, Gregoroff J, Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995; 182: 431-7.
8. Aruffo A, Stamenkovic I, Melnick M, Underhill B, Seed B. CD44 is the principal cell surface receptor for hialuronate. Cell 1990; 61: 1303-10.
9. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
10. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behaviour. Cancer Res 1995; 55: 428-33.
11. van Muijen GN, Danen EH, Veerkamp JH, Ruher DJ, Lesley J, van den Heuvel LP. Glycoconjugate profile and CD44 expression on human melanoma cell lines with different metastatic capacity. Int J Cancer 1995; 61: 241-8.
12. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180: 53-66.
13. Ruggiero R, Bustuoabad O, Bonfil D, Mesiss R, Pasqualini CD. Concomitant immunity in murine tumours of non-detectable immunogenecity. Br J Cancer 1984; 51: 1-10.
14. Lugasi H, Hajos S, Murphy JR, et al. Murine spontaneous T-cell leukaemia constitutively expressing IL-2R. A model for human T cell malignancies expressing IL-2R. Int J Cancer 1990; 45: 163-7.
15. Zahalka MA, Okon E, Gosslar U, Holzmann B, Naor D. Lymph node (but not spleen) invasion by murine lymphoma is both CD44-and hyaluronate-dependent. J Immunol 1995; 154: 5345-55.
16. Vogt Sionov R, Naor D. Hyaluronan-independent logdment of CD44+ lymphoma cells in lymphoid organs. Int J Cancer 1997;71:462-9
17. Cupis de A, Pirani P, Fazzuoli L, Favoni RE. Responsivess to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures. In Vitro Cell Dev Biol 1998; 34: 836-43.
18. Waldner C, Mongini C, Alvarez E, Roig I, Hajos SE. Inhibitory activity of soluble IL-2R in sera, ascites and culture supernalants from murine leukemics cells. Scand J Immunol 1994; 40: 308-16.
19. Sgonc R, Wick G. Methods for detection of Apoptosis. Int Arch Allergy 1994; 105: 327-32.
20. Weinber RA. The integration of molecular genetics into cancer management. Cancer 1991; 70: 1653-8.
21. Gunthert U, Hoffman M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-9.
22. Thomas L, Byers R, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on Hialuronate-coated substrate. J Cell Biol 1992; 118: 971-80.
23. Malek T, Porter BO, Wen HE Y. Mutiples δc-dependent cytoquines regulate T-cell development. Immunology Today 1999; 20: 72-8.
24. Borland G, Ross JA, Guy K. Formas and functions of CD44. Immunology 1998; 93: 139-48.
25. Sionov RV, Naor D. Hyaluronan-independent lodgment of CD44+ Lymphoid organs. Int J Cancer 1997; 462-9.